WallStreetZenWallStreetZen

NASDAQ: LMAT
Lemaitre Vascular Inc Earnings & Revenue

LMAT past earnings growth

How has LMAT's earnings growth performed historically?
Company
62.77%
Industry
32.68%
Market
119.55%
LMAT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LMAT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LMAT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LMAT past revenue growth

How has LMAT's revenue growth performed historically?
Company
18.16%
Industry
7.93%
Market
15.78%
LMAT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LMAT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LMAT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LMAT earnings and revenue history

Current Revenue
$199.9M
Current Earnings
$34.0M
Current Profit Margin
17%
LMAT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

LMAT Return on Equity

Current Company
11.5%
Current Industry
11.6%
Current Market
28.2%
LMAT's Return on Equity (11.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LMAT announces earnings.

LMAT Return on Assets

Current Company
10%
Current Industry
7.9%
LMAT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LMAT Return on Capital Employed

Current Company
13.53%
Current Industry
10.3%
LMAT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LMAT vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LMAT$199.89M$53.80M$33.95M+13.09%+5.69%
STAA$326.24M$25.02M$15.30M+20.31%+19.74%
WRBY$697.80M-$21.09M-$55.06M+12.12%N/A
ATRC$414.60M-$13.25M-$37.23M+14.73%N/A
ICUI$2.26B$244.95M-$59.31M+10.68%N/A

Lemaitre Vascular Earnings & Revenue FAQ

What were LMAT's earnings last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q1 2024 earnings per share (EPS) of $0.44, up 62.96% year over year. Total Lemaitre Vascular earnings for the quarter were $9.89 million. In the same quarter last year, Lemaitre Vascular's earnings per share (EPS) was $0.27.

If you're new to stock investing, here's how to buy Lemaitre Vascular stock.

What was LMAT's earnings growth in the past year?

As of Q2 2024, Lemaitre Vascular's earnings has grown 62.77% year over year. This is 30.09 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 32.68%. Lemaitre Vascular's earnings in the past year totalled $33.95 million.

What was LMAT's revenue last quarter?

On Invalid Date, Lemaitre Vascular (NASDAQ: LMAT) reported Q1 2024 revenue of $53.48 million up 13.6% year over year. In the same quarter last year, Lemaitre Vascular's revenue was $47.08 million.

What was LMAT's revenue growth in the past year?

As of Q2 2024, Lemaitre Vascular's revenue has grown 18.16% year over year. This is 10.23 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.93%. Lemaitre Vascular's revenue in the past year totalled $199.89 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.